Items Tagged ‘Dr. Jacob Ziegler’
January 17, 2020
Mayo Clinic in the News Weekly Highlights for January 17, 2020
USA Today, Drinking tea regularly may help you live longer and healthier, new study finds by Joshua Bote — The study also acknowledged that the positive benefits of tea were more robust in men than women. Dr. Eugenia Gianos, the director of women’s heart health at New York City’s Lenox Hill Hospital, said that may […]
Tags: aging, AI, alzheimer's disease, artificial Intelligence, birth defects, brain health, Cheeriodicals, cross-country skiing, cystic fibrosis, diabetes, Don Elliott, Dr. Angela Mattke
September 20, 2019
Mayo Clinic in the News Weekly Highlights for September 20, 2019
Wall Street Journal, Israel Prepares to Unleash AI on Health Care by Dov Lieber — Israel is becoming a testing ground for the power of artificial intelligence to improve health care… In May, Israel’s Innovation Authority signed a memorandum with the Mayo Clinic for Israeli health startups to team up with the U.S. institution’s researchers […]
Tags: ADHD, aging, AI, alzheimer's disease, Apple Tree Dental, artificial Intelligence, Ben Crenshaw, BioSig, Blood Donor Program, board of trustees, bone marrow transplant, C. diff
April 5, 2019
Mayo Clinic in the News Weekly Highlights for April 5, 2019
Wall Street Journal, What AI Can Tell From Listening to You by John McCormick — The Mayo Clinic conducted a two-year study that ended in February 2017 to see if voice analysis was capable of detecting coronary-artery disease. Every person’s voice has different frequencies that can be analyzed, explains Amir Lerman, director of the Cardiovascular […]
Tags: acoustic neuroma, AI, Allie Metzler, alzheimer's disease, artificial Intelligence, back pain, Beth Dittbenner, Beyond Verbal, BIOMEX, brain tumor, breast cancer screening, Breath Diagnostics
March 29, 2019
Mayo Clinic in the News Weekly Highlights for March 29, 2019
Reuters, Biogen scraps two Alzheimer drug trials, wipes $18 billion from market value by Julie Steenhuysen — Biogen Inc and partner Eisai Co Ltd are ending two late-stage trials of their experimental Alzheimer’s disease drug aducanumab, a major setback in the quest to find a treatment for the mind-wasting disease and a blow to Biogen, […]
Tags: AliveCor, alzheimer's disease, anal cancer, artificial Intelligence, Biogen, blood donation, Blood Donor Program, caffeine, cognitive decline, dementia, depression, Derrick Rose